Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952079 · ClinicalTrials.gov registry record · NA
Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis
A NA study, sponsored by University of the Incarnate Word.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02952079 is a NA study that has completed, run by University of the Incarnate Word. The registered enrollment target is 11 participants.
The verdict
NCT02952079, a NA study, has completed, sponsored by University of the Incarnate Word.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this study is to compare which treatment - BlephEx or MiBoFlo - will be a better option for patients suffering from dry eye secondary to Meibomian Gland dysfunction.
Interventions
- DEVICE Blephex
- DEVICE MiboFlo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02952079
The ClinicalTrials.gov registry entry for NCT02952079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of the Incarnate Word, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blephex is the first listed.
NCT02952079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02952079 about?
NCT02952079 is a clinical study titled "Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis". The goal of this study is to compare which treatment - BlephEx or MiBoFlo - will be a better option for patients suffering from dry eye secondary to Meibomian Gland dysfunction.
What is the current status of trial NCT02952079?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2015-05. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02952079?
The interventions under investigation include: Blephex (DEVICE), MiboFlo (DEVICE).
Who is sponsoring clinical trial NCT02952079?
This trial is sponsored by University of the Incarnate Word, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.